~~<i id='84A6BC6A98'><strike id='84A6BC6A98'><tt id='84A6BC6A98'><pre id='84A6BC6A98'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：Wikipedia 2025-08-12 06:42:34 - browse：12

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Vertigo drug brings hope for rare neuron disorder, Niemann

explore

hotspot

Wikipedia

focus

explore

leisure time

Rep.BradWenstrup(R-Ohio)AnnaMoneymaker/GettyImagesWASHINGTON—HouseRepublicanshaverepeatedlyaccusedBi

WSS

How doctors’ personal politics affect patients

Even great ERs can’t make up for American health disparities

Cognito secures funding to test medical device for Alzheimer's

What we need to know about Arena Bioworks

UHS says company favors patients whose insurance pays more

Medicare drug price negotiation’s day in court

knowledge

fashion

explore

Continuity nursing helped my family in our darkest PICU moments

Commercial surrogacy can be ethical, despite pope’s claims

What does generative AI mean for health care? We asked experts

New lawsuit accuses health insurer Cigna of denying claims in bulk

New air purifier tech could be key to improving indoor air quality

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Alkermes shareholders re

What we need to know about Arena Bioworks

Moonlake's readout produced a cash windfall. Risks remain

Biden warns of ‘dark winter’ during final presidental debate

hotspot

How doctors’ personal politics affect patients

Roche’s Alnylam deal shows drug firms interested in heart drugs

What we need to know about Arena Bioworks

New Alzheimer's drugs heat up race for early detection blood tests

General Catalyst, Summa Health deal will turn on physician buy

Even great ERs can’t make up for American health disparities

Wikipedia

focus

explore

leisure time